Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company's ultra sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanter

SCIENTIST, CLINICAL ASSAY VALIDATION BILLERICA, MA Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company's ultra sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomar

We are looking for an experienced and highly motivated Director, Assay Development to drive continued growth and expansion of our portfolio of ultrasensitive Simoa immunoassays. This is a high impact role with responsibility for leading development of clinically and commercially significant Simoa biomarker assays. You will use your technical and managerial skills and expe

Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company's ultra sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanter

RESEARCH ASSOCIATE, PRODUCT TRANSFER BILLERICA, MA Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company's ultra sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomar

Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company's ultra sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanter

Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company's ultra sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanter

Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company's ultra sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanter

Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company's ultra sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanter

Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company's ultra sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanter

Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company's ultra sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanter

Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company's ultra sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanter

Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company's ultra sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanter

Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company's ultra sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanter

Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company's ultra sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanter